Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICD Pharma is an Israeli clinical-stage pharmaceutical company developing cannabis-based therapies for medical cannabis and longer-term drug-development applications. The company focuses on oral and topical cannabinoid formulations built on a portfolio of proprietary pharmaceutical delivery technologies. Publicly available descriptions position ICD Pharma as a small private company based in Rehovot, Israel, with founders including Eran Perry and Doron Friedman. While third-party sources consistently describe the company as active and clinical-stage, detailed public disclosure on named pipeline assets, molecular targets, and specific lead indications appears limited.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ICD Pharma.